Chargement en cours...
Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
Metastatic breast cancer (MBC) remains an incurable disease, with the goals of care aimed at maximizing the patient’s duration and quality of life. Treatment options for MBC have become more efficacious and numerous. In addition to endocrine and chemotherapy agents, a number of targeted agents, incl...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3233277/ https://ncbi.nlm.nih.gov/pubmed/22162924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S16392 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|